Bastide Le Confort Medical annual debt-to-ebitda ratio
2021
2022
2023
2024
2025
Bastide Le Confort Medical Debt-to-EBITDA Ratio Growth & History (BLC)
Bastide Le Confort Medical's debt-to-ebitda ratio was 0.58 for fiscal 2025.
View full Bastide Le Confort Medical company overviewBastide Le Confort Medical annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 0.58 | −0.20 | −25.82% |
| 2024 | 2024-06-30 | 0.78 | −0.02 | −2.44% |
| 2023 | 2023-06-30 | 0.80 | −0.14 | −14.93% |
| 2022 | 2022-06-30 | 0.94 | −0.16 | −14.54% |
| 2021 | 2021-06-30 | 1.10 | — | — |
Bastide Le Confort Medical debt-to-ebitda ratio trends
Between the periods ended 2021-06-30 and 2025-06-30, Bastide Le Confort Medical's debt-to-ebitda ratio decreased from 1.10 to 0.58, a change of −0.52.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bastide Le Confort Medical source filings ↗